Omnicell (OMCL) Misses Q4 EPS by 10c, Beats on Revenue; Offers FY26 Guidance

Omnicell (NASDAQ: OMCL) reported Q4 EPS of $0.40, $0.10 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $314 million versus the consensus estimate of $313.39 million.

GUIDANCE:

Omnicell sees FY2026 EPS of $1.65-$1.85, versus the consensus of $1.72. Omnicell sees FY2026 revenue of $1.22-1.26 billion, versus the consensus of $1.18 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Rosenblatt Starts SanDisk (SNDK) at Buy
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk